Innoviva, Inc. (INVA)
20.00
+0.25
(+1.27%)
USD |
NASDAQ |
Jan 30, 16:00
20.00
0.00 (0.00%)
After-Hours: 20:00
Innoviva Shareholders Equity (Quarterly) : 1.010B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 51.85B |
| Pfizer Inc. | 92.80B |
| Bristol Myers Squibb Co. | 18.55B |
| Nektar Therapeutics | 85.09M |
| Oramed Pharmaceuticals, Inc. | 203.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.429B |
| Total Liabilities (Quarterly) | 419.16M |
| Debt to Equity Ratio | 0.2564 |
| Current Ratio | 14.12 |
| Net Debt Paydown Yield | 2.81% |